BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Yang L. Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue. Front Public Health 2022;10:908757. [DOI: 10.3389/fpubh.2022.908757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Doğan H, Kara A, Çankaya E, Balkan E, Gürbüz MA, Kızılkaya M, Aykaç M. Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients. Curr Issues Mol Biol 2023;45:963-74. [PMID: 36826007 DOI: 10.3390/cimb45020062] [Reference Citation Analysis]
2 Kawall A, Lewis DSM, Sharma A, Chavada K, Deshmukh R, Rayalam S, Mody V, Taval S. Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity. Front Chem 2022;10:1100460. [PMID: 36712981 DOI: 10.3389/fchem.2022.1100460] [Reference Citation Analysis]
3 Zhang K, Wang L, Peng J, Sangji K, Luo Y, Zeng Y, Zeweng Y, Fan G. Traditional Tibetan medicine to fight against COVID-19: Basic theory and therapeutic drugs. Front Pharmacol 2023;14:1098253. [PMID: 36874035 DOI: 10.3389/fphar.2023.1098253] [Reference Citation Analysis]
4 Giotis ES, Cil E, Brooke GN. Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients. Viruses 2022;14. [PMID: 36560732 DOI: 10.3390/v14122728] [Reference Citation Analysis]
5 Wang Z, Yang L, Song XQ. Oral GS-441524 derivatives: Next-generation inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase. Front Immunol 2022;13:1015355. [PMID: 36561747 DOI: 10.3389/fimmu.2022.1015355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Yi Y, Fang J, Liu Y, Gao Y, Lin W, Hao D, Zhang X, Zhang M. Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment. IJGM 2022;Volume 15:8191-8200. [DOI: 10.2147/ijgm.s391024] [Reference Citation Analysis]
7 Wang Z, Wang N, Yang L, Song X. Bioactive natural products in COVID-19 therapy. Front Pharmacol 2022;13:926507. [DOI: 10.3389/fphar.2022.926507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu Y, Chen X, Wang H, Yao C, Gou X, Gao Z, Sun L, Liu D, Tang C, Wei Y, Ding Q, Yang H, Lin J, Chen K, Chen J, Zhao L, Li M, Han L, Wang J, Ren J, Zhang Y. Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial. Front Pharmacol 2022;13:936925. [DOI: 10.3389/fphar.2022.936925] [Reference Citation Analysis]